What is the differential diagnosis (Ddx) for non-erythematous facial papules that appear umbilicated, primarily on the cheeks bilaterally?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis for Non-Erythematous Umbilicated Facial Papules on Bilateral Cheeks

The most likely diagnosis is molluscum contagiosum, which characteristically presents as shiny, dome-shaped umbilicated papules that are non-erythematous and can occur bilaterally on the face, particularly in children and immunocompromised individuals. 1

Primary Diagnosis: Molluscum Contagiosum

Molluscum contagiosum should be your first consideration given the classic umbilicated appearance and bilateral cheek distribution. 1

Clinical Features Supporting This Diagnosis:

  • Appearance: Single or multiple shiny, dome-shaped umbilicated lesions that are typically 2-5 mm in size, whitish, pink, or skin-colored 1, 2
  • Distribution: Can occur anywhere on the face, with bilateral presentation being common 2, 3
  • Surface characteristics: Smooth, shiny surface with central umbilication (the pathognomonic feature) 1, 2
  • Associated findings: May have pruritus, though lesions themselves are typically non-tender 1

Diagnostic Confirmation:

  • Clinical diagnosis is usually sufficient when the classic umbilicated appearance is present 2, 3
  • Dermoscopy reveals yellowish-white polylobulated structures with peripheral telangiectasia, which can confirm the diagnosis non-invasively 2, 3
  • Skin biopsy is reserved for atypical presentations or diagnostic uncertainty 2

Key Populations at Risk:

  • Children (most common demographic) 1, 2, 4
  • Immunocompromised patients (HIV, transplant recipients, those on immunosuppressive therapy) may present with multiple, larger, or atypical lesions 1, 5
  • Sexually active adults (though facial lesions are less commonly sexually transmitted) 2, 4

Alternative Differential Diagnoses to Consider

1. Cutaneous Cryptococcosis (in Immunocompromised Patients)

  • Can present as umbilicated papules mimicking molluscum contagiosum 1
  • Key distinguishing features: More common in severely immunocompromised patients, may have systemic symptoms 1
  • Requires skin biopsy with fungal stains and culture for definitive diagnosis 1, 6

2. Disseminated Fungal Infections

  • Aspergillus and other invasive fungi can cause cutaneous lesions that begin as erythematous papules but may become pustular with central ulceration 1, 6
  • Critical distinction: These typically have an erythematous base and occur in neutropenic or severely immunocompromised patients 1
  • Less likely given the non-erythematous presentation described 1

3. Basal Cell Carcinoma (Nodular Type)

  • Can occasionally present with central umbilication 2
  • Key differences: Usually solitary, occurs in older adults with sun exposure history, pearly appearance with telangiectasias 2
  • Bilateral symmetric presentation on cheeks would be unusual

4. Atypical Molluscum Presentations

  • Giant molluscum: Lesions >1 cm, more common in immunocompromised patients 3
  • Disseminated molluscum: Multiple widespread lesions in immunosuppressed individuals 3
  • Inflammatory variants: May have surrounding erythema (perilesional eczema, BOTE sign) 3

Clinical Pitfalls to Avoid

Common Diagnostic Errors:

  • Assuming all umbilicated lesions are benign: In immunocompromised patients, always consider opportunistic infections including cryptococcosis and disseminated fungal infections 1, 6
  • Missing immunocompromised status: Always assess immune status, as this dramatically changes the differential and management approach 1, 5
  • Overlooking the need for biopsy: When lesions are atypical, rapidly progressive, or in immunocompromised patients, biopsy with histology and culture is essential 1, 6

Red Flags Requiring Immediate Further Investigation:

  • Rapidly enlarging lesions (>1 cm in <24 hours) suggest aggressive infection like ecthyma gangrenosum 1
  • Systemic symptoms (fever, malaise) with skin lesions in immunocompromised patients 1
  • Necrotic centers developing in previously umbilicated lesions 1
  • Known severe immunosuppression (neutropenia, HIV with low CD4 count, transplant recipients) 1

Management Approach

For Immunocompetent Patients with Classic Molluscum:

  • Observation is reasonable as lesions typically self-resolve in 6-12 months 7, 2
  • Active treatment is indicated for extensive disease, cosmetic concerns, or to prevent autoinoculation 1, 2, 5
  • Treatment options include cryotherapy, curettage, or topical agents (though specific agents should be age-appropriate) 7, 2

For Immunocompromised Patients:

  • Biopsy or aspiration should be performed early to obtain material for histological and microbiological evaluation 1, 6
  • Consider both bacterial and fungal cultures, as well as histopathology 1, 6
  • Empiric antimicrobial therapy may be necessary while awaiting culture results in severely immunocompromised patients with systemic symptoms 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Skin reactions related to molluscum contagiosum infection].

Andes pediatrica : revista Chilena de pediatria, 2024

Research

Molluscum contagiosum.

Dermatology online journal, 2003

Guideline

Fungal Infections Resembling Acanthosis Nigricans

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Molluscum Contagiosum Treatment Considerations in Young Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.